Study to Evaluate the Efficacy and Safety of Sirolimus in Subjects With Metastatic, Mismatch Repair Deficient Solid Tumors After Immunotherapy
Clinical trial NCT04393454 · TERMINATED
Trial details
- NCT number
- NCT04393454
- Sponsor
- Albert Einstein College of Medicine
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-16
- Primary completion
- 2023-05-16
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.